Related Experiment Video
Updated: Dec 26, 2025

06:33
Massive Pontine Hemorrhage by Dual Injection of Autologous Blood
Published on: May 29, 2021
4.5K
Leech Me Alone! Atraumatic Hemarthrosis after Hirudotherapy.
Janine Curcio1, Christopher M Lloyd1
1Emergency Medicine, OhioHealth Doctors Hospital, Columbus, USA.
Cureus
|March 20, 2020
Summary
Leech therapy, used for osteoarthritis and joint pain, can cause rare intra-articular bleeding (hemarthrosis) in the knee. Physicians should consider this risk when patients report joint pain after leech therapy.
Area of Science:
- Integrative Medicine
- Orthopedic Surgery
- Dermatology
Background:
- Hirudotherapy (leech therapy) is increasingly used for conditions like osteoarthritis and in reconstructive surgery.
- Commonly reported adverse events include cutaneous reactions, bleeding, and infection.
- Intra-articular bleeding following hirudotherapy is an infrequently documented complication.
Observation:
- A 58-year-old male experienced knee pain and swelling following leech therapy.
- Knee aspiration revealed significant hemarthrosis (bleeding into the joint).
Findings:
- Intra-articular bleeding is a potential, though uncommon, adverse event associated with hirudotherapy.
- This case highlights a rare complication of leech therapy in the knee joint.
Implications:
- Physicians should be aware of hemarthrosis as a possible adverse reaction to hirudotherapy, especially when used for joint pain.
- This underscores the need for careful patient selection and monitoring for patients undergoing leech therapy.
Related Concept Videos
Introduction to Hemostasis
12.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
12.7K
Venous Thrombosis III: Interprofessional Care
220
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
220
Venous Thrombosis IV: Nursing Management
153
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
153
Extrinsic and Intrinsic Pathways of Hemostasis
11.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.4K
Disorders of Hemostasis
1.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.5K

